9-Phenyl-3,6-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)carbazole>98.0%(HPLC)(N)1g

2,4,6-Trihydroxy-3-methylbenzaldehyde, 97%, 100mg

(4-(N-Ethyl-N-(4-methoxybenzyl)sulfamoyl)phenyl)boronic acid, 95.0%, 1g

2-Acetylamino-thiazole-5-sulfonyl chloride, 95.0%, 100mg

6-(Benzyloxy)-9H-purine, 95.0%, 25g

2-(3-Nitrophenyl)ethanamine hydrochloride, 95.0%, 10g

(R)-4-(1-Aminoethyl)phenol hydrochloride, 97.0%, 25g

1-((11bR)-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)-3,5-dimethylpiperidine, 97%, 1g

4-Acetyl-2-methoxybenzoic acid, 95%, 5g

Methyl 2-oxo-2,3-dihydro-1H-pyrrolo[3,2-b]pyridine-5-carboxylate, 95.0%, 1g

Cuba de muestra, 300 pieza(s)

5-Bromo-3-chloro-2-iodotoluene, 95.0%, 5g

(R)-(3-Pyrrolidin-2-yl-propyl)-carbamic acid tert-butyl ester, 95.0%, 250mg